Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL
Clinical trial NCT04156659 · WITHDRAWN
Trial details
- NCT number
- NCT04156659
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2022-11-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.